
    
      This is a phase I/II study of high dose irinotecan in patients with recurrent unresectable
      malignant glioma on steroids/anti-epileptics. The purpose is to compare the response to
      treatment and side effects associated with high dose irinotecan in patients with recurrent
      brain tumors.
    
  